Immediate Impact
41 standout
Citing Papers
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
2024 Standout
Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications
2024 Standout
Works of Hiroaki Ihara being referenced
Severe gastritis due to pembrolizumab treatment in a lung cancer patient
2020
Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hiroaki Ihara | 176 | 42 | 44 | 63 | 61 | 27 | 287 | |
| Kana Kurokawa | 133 | 36 | 24 | 49 | 77 | 22 | 266 | |
| D. B. Whitehouse | 143 | 35 | 33 | 79 | 29 | 20 | 303 | |
| Naoki Watanabe | 168 | 35 | 33 | 60 | 107 | 34 | 303 | |
| Jing Geng | 160 | 26 | 35 | 61 | 20 | 27 | 245 | |
| Yongfu Wang | 89 | 22 | 21 | 82 | 19 | 18 | 257 | |
| Hironobu Sugita | 158 | 28 | 33 | 89 | 27 | 28 | 279 | |
| Tapan Bhavsar | 74 | 32 | 37 | 77 | 84 | 23 | 324 | |
| Assaf Stein | 69 | 44 | 36 | 105 | 106 | 22 | 313 | |
| Jørgen Bichel | 48 | 46 | 26 | 48 | 52 | 39 | 320 | |
| Yingying Chen | 104 | 50 | 17 | 84 | 38 | 25 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...